Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control

Claire Lhuillier, Nils-Petter Rudqvist, Takahiro Yamazaki, +9

Journal of Clinical Investigation

Tumor ControlImmunologyImmunoeditingCd4 T Cell ResponsesImmunotherapy +14

CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair

Maud Charpentier, Ahmed Khedher, Séverine Ménoret, +13

Nature Communications

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells

Catherine Rabu, Laurie Rangan, Laëtitia Florenceau, +10

OncoImmunology

Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors

Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier, +9

Nature Communications

IRES-dependent translation of the long non coding RNA <i>meloe</i> in melanoma cells produces the most immunogenic MELOE antigens

Maud Charpentier, Mikaël Croyal, Delphine Carbonnelle, +6

Oncotarget

ImmunologyImmune RegulationImmunoeditingImmunologic MechanismImmunotherapeutics +25

Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses

Karsten A. Pilones, Maud Charpentier, Elena García-Martínez, +5

Cancer Immunology Research

Atherosclerosis Associated with Pericardial Effusion in a Central Bearded Dragon (<i>Pogona Vitticeps</i>)

Lionel Schilliger, Karin Lemberger, Norin Chai, +2

Journal of Veterinary Diagnostic Investigation

The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences

Delphine Carbonnelle, Virginie Vignard, Delphine Séhédic, +6

PLoS ONE

Melanoma Antigens Meloe-1Meloe-2 Are TranslatedSystems BiologyMeloe Rna DegradationMeloe Mrna +10

hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote MELOE‐1 translation in stressed melanoma cells

Maud Charpentier, Émilie Dupré, Agnès Fortun, +7

Molecular Oncology

ImmunologyImmunoeditingImmunotherapyCancer BiologyMelanoma Cells +19

[Renal medullary carcinoma, a new clinico-pathological entity. Immunohistochemical, ultrastructural, flow cytometric and cytogenetic study of a case].

Denis Chatelain, Gonzague de Pinieux, J Sláma, +5

PubMed